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Conclusion: in pts with severe AS and preserved LVEF there is a rela-
tively wide range of CFR values. CFR is more severely impaired in symptom-
atic pts and is mainly determined by increased LV wall stress and workload,
and diastolic dysfunction.
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Purpose: The detection of subclinical atherosclerosis with the new nonin-
vasive imaging techniques coupled radiofrequency (RF) echo 2D, allows us to
study the remodeling of the arterial wall to evaluate the progression of athero-
sclerosis and risk stratification in patients with cardiovascular risk factors.
These techniques can be used in individual or mass screening for patients with
risk factors in intermediate- risk priority to stratify their risk and start a sup-
port targeted to change the markers integrators (decrease the degree of abnor-
mality) and standardize bios markers and reduce the occurrence of
cardiovascular events vascular medium and long term, associated with control
of cardiovascular risk factors.
Description of methods: the methods by Radio Frequency (RF) coupled
to the 2D echo: The VIF Method (vasodilatation by means of flow) allows an
analysis of degree of endothelial dysfunction, QIMT: measurement of intima
media thickness, QAS: study of arterial stiffness by measuring the velocity of
the pulse wave (PWV) and stiffness parameters alpha and beta). Techniques
with a sensitivity of 90% and specificity of 92%.
Other promising new techniques that can be used in addition: PVI echo
particle image velocimetry (measuring wall shear stress, velocity vector anal-
ysis of blood flow at the carotid bifurcation and MRI velocimetry: stress mea-
surement by marking protons to even finer detection of the alteration of the
arterial wall. Techniques which allow finer detection of atherosclerosis, the
earliest changes in the arterial wall, but remain expensive and cumbersome
and not accessible in daily practice.
Conclusion: All of these techniques can be used in screening and early
detection of subclinical atherosclerosis, and must be systematically associated
with the analysis of biomarkers (biological, bio-chemical markers of oxidative
stress). The application of this new screening protocol of subclinical athero-
sclerosis, combined with targeted support will enable us to better detection
and to develop preventive cardiology.
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Introduction: The cardiovascular complications are the leading cause of
morbidity and mortality in chronic hemodialysis patients. These patients fre-
quently have calcifications in vascular tissue. The aim of our study is to deter-
mine the prevalence of cardiac calcification in a population of chronic
hemodialysis and to identify the parameters associated with risk of occurrence
of cardiac calcification.
Patients and methods: This is a cross-sectional study was conducted over
a period of three months, included 44 patients with chronic hemodialysis. Data
collection was conducted through the history, study records, the study of
books dialysis and results of echocardiography. We analyzed sex, age at the
time of the study, the presence or absence of history of hypertension, obesity,
duration on dialysis, serum calcium, phosphate, intact parathyroid hormone
and drug intake carbonate calcium, sevelamer and alfacalcidol. Transthoracic
echocardiography sought cardiac calcifications and their seats.
Results: These 44 patients including 22 (50%) were male and 22 (50%)
female. The average age of 44.1±11.8 years and average duration of hemodi-
alysis was 9.5±4.9 years. The prevalence of cardiac calcification in our
patients is 43.2%. only duration of hemodialysis is associated with risk of
occurence of cardiac calcification in our series as age, sex, obesity, history of
hypertension, drug intake, calcemia, phosphoremia and parathyroid hormone
does not seem to affect the risk of occurrence of this complication.
Discussion: The occurrence of soft tissue calcification is common in
patients with chronic kidney diseases, which may occur especially in hemo-
dialysis patients. Calcification in chronic hemodialysis patients is a factor of
morbidity and mortality of growing concern.
Conclusion: this study showed that the prevalence of cardiac calcification
in hemodialysis patients is high. Their research should be systematic to iden-
tify patients with high risk and to guide therapeutic management.
155
Subclinical left ventricular dysfunction in asymptomatic scleroderma
patients
Thouraya Filali [Orateur], Faida Ajili, Dhaker Lahidheb, Mehdi Gommidh,
Badii Jdaida, Nadhem Hajlaoui, Imene Saaidi, Abdedayem Hagui, Wafa
Fehri, Habib Haouala
Hôpital Militaire de Tunis, Cardiologie, Tunis, Tunisie
Purpose: Scleroderma has been associated with an increased risk of car-
diovascular diseases. The aim of this study is to assess the systolic and dias-
tolic function of the left ventricle (LV) in asymptomatic scleroderma patients.
Methods: We included twenty scleroderma patients without symptoms or
signs of heart failure or angina (group I), and 20 healthy subjects (group II).
The 2 groups had similar mean age, sex ratio, mean blood pressure and body
mass index. All included subjects had no evidence of diabetes mellitus, val-
vular or ischemic heart diseases. We used standard echocardiography and
tissue Doppler imaging (TDI).
Results: LV diastolic diameter, LV ejection fraction and the Tei index
were similar in both groups. However, we observed lower mitral annulus sys-
tolic velocities measured by TDI in scleroderma patients (3.8±0.8 cm/s vs.
7.5±1 cm/s, p<0.01) reflecting subclinical LV systolic dysfunction. There was
no significant difference in the ratio of early to late diastolic mitral filling
velocities E/A and in deceleration time of E between the 2 groups. However,
mitral annulus early diastolic velocities Em measured by TDI were markedly
reduced in scleroderma patients (7.1± 0.8 cm/s vs. 13.4±1.5 cm/s, P <0.01)
with higher ratio of E/Em velocities (14.1± 1.5 vs. 7.3± 1.3; p<0.01) sug-
gesting impaired diastolic function.
Conclusion: This study shows the presence of LV systolic and diastolic
dysfunctions in asymptomatic scleroderma patients. Tissue Doppler imaging
may provide a useful tool to monitor the disease process and treatment
response of this subclinical myocardial dysfunction.
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Background: Previous care reports have suggested that dobutamine stress
echocardiography may induce coronary artery spasm. The aim of this study
was to assess the prevalence of coronary artery spasm during dobutamine
stress echocardiography.
Methods: Over a nine-year period (from November 2001 to October
2010), we reviewed all patients (n=2.224) referred for dobutamine stress
echocardiography. Criteria for selection included patients aged >18 years and
with dobutamine stress echocardiography. We systematically analyzed all
ECG performed during dobutamine stress echocardiography, allowing to
detect ST elevation during the examination. All patients with ST elevation
underwent a coronary angiography.
Results: A dobutamine stress echocardiography was performed in
2,224 patients. In 20 patients, a ST elevation was observed (always in infe-
